Clinical Trials
6 trialsNCT02194738 2026-05-13
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
Phase NA Active not recruiting
NCT02595944 2026-05-13
ANVIL
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT02193282 2026-05-04
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT07239544 2025-11-20
Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines
The First Affiliated Hospital of Soochow University
Active not recruiting
NCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT06008353 2024-12-19
EDUR-BRA
AstraZeneca
Active not recruiting